BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hellebrekers DM, Griffioen AW, van Engeland M. Dual targeting of epigenetic therapy in cancer. Biochim Biophys Acta. 2007;1775:76-91. [PMID: 16930846 DOI: 10.1016/j.bbcan.2006.07.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 50] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Tan HW, Xu YM, Qin SH, Chen GF, Lau ATY. Epigenetic regulation of angiogenesis in lung cancer. J Cell Physiol 2021;236:3194-206. [PMID: 33078404 DOI: 10.1002/jcp.30104] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Glass K, Quackenbush J, Spentzos D, Haibe-Kains B, Yuan GC. A network model for angiogenesis in ovarian cancer. BMC Bioinformatics 2015;16:115. [PMID: 25888305 DOI: 10.1186/s12859-015-0551-y] [Cited by in Crossref: 45] [Cited by in F6Publishing: 28] [Article Influence: 7.5] [Reference Citation Analysis]
3 Khemlina G, Ikeda S, Kurzrock R. The biology of Hepatocellular carcinoma: implications for genomic and immune therapies. Mol Cancer. 2017;16:149. [PMID: 28854942 DOI: 10.1186/s12943-017-0712-x] [Cited by in Crossref: 117] [Cited by in F6Publishing: 102] [Article Influence: 29.3] [Reference Citation Analysis]
4 Su C, Yen C, Chiang C, Hsu C, Chen S. Multistage Continuous Targeting with Quantitatively Controlled Peptides on Chitosan-Lipid Nanoparticles with Multicore-Shell Nanoarchitecture for Enhanced Orally Administrated Anticancer In Vitro and In Vivo. Macromol Biosci 2017;17:1600260. [DOI: 10.1002/mabi.201600260] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
5 Dworkin AM, Huang TH, Toland AE. Epigenetic alterations in the breast: Implications for breast cancer detection, prognosis and treatment. Semin Cancer Biol 2009;19:165-71. [PMID: 19429480 DOI: 10.1016/j.semcancer.2009.02.007] [Cited by in Crossref: 104] [Cited by in F6Publishing: 95] [Article Influence: 8.7] [Reference Citation Analysis]
6 Song C, Zhu S, Wu C, Kang J. Histone deacetylase (HDAC) 10 suppresses cervical cancer metastasis through inhibition of matrix metalloproteinase (MMP) 2 and 9 expression. J Biol Chem 2013;288:28021-33. [PMID: 23897811 DOI: 10.1074/jbc.M113.498758] [Cited by in Crossref: 77] [Cited by in F6Publishing: 46] [Article Influence: 9.6] [Reference Citation Analysis]
7 Rausch M, Weiss A, Zoetemelk M, Piersma SR, Jimenez CR, van Beijnum JR, Nowak-Sliwinska P. Optimized Combination of HDACI and TKI Efficiently Inhibits Metabolic Activity in Renal Cell Carcinoma and Overcomes Sunitinib Resistance. Cancers (Basel) 2020;12:E3172. [PMID: 33126775 DOI: 10.3390/cancers12113172] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
8 Provenzano MJ, Domann FE. A role for epigenetics in hearing: Establishment and maintenance of auditory specific gene expression patterns. Hear Res 2007;233:1-13. [PMID: 17723285 DOI: 10.1016/j.heares.2007.07.002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
9 Meeran SM, Ahmed A, Tollefsbol TO. Epigenetic targets of bioactive dietary components for cancer prevention and therapy. Clin Epigenetics. 2010;1:101-116. [PMID: 21258631 DOI: 10.1007/s13148-010-0011-5] [Cited by in Crossref: 146] [Cited by in F6Publishing: 118] [Article Influence: 13.3] [Reference Citation Analysis]
10 Pacheco MB, Camilo V, Lopes N, Moreira-Silva F, Correia MP, Henrique R, Jerónimo C. Hydralazine and Panobinostat Attenuate Malignant Properties of Prostate Cancer Cell Lines. Pharmaceuticals (Basel) 2021;14:670. [PMID: 34358096 DOI: 10.3390/ph14070670] [Reference Citation Analysis]
11 Komorowsky C, Ocker M, Goppelt‐struebe M. Differential regulation of connective tissue growth factor in renal cells by histone deacetylase inhibitors. Journal of Cellular and Molecular Medicine 2009;13:2353-64. [DOI: 10.1111/j.1582-4934.2008.00674.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
12 Buysschaert I, Schmidt T, Roncal C, Carmeliet P, Lambrechts D. Genetics, epigenetics and pharmaco-(epi)genomics in angiogenesis. J Cell Mol Med 2008;12:2533-51. [PMID: 19210754 DOI: 10.1111/j.1582-4934.2008.00515.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
13 Bomsztyk K, Denisenko O. Epigenetic alterations in acute kidney injury. Semin Nephrol 2013;33:327-40. [PMID: 24011575 DOI: 10.1016/j.semnephrol.2013.05.005] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
14 Kato K, Long NK, Makita H, Toida M, Yamashita T, Hatakeyama D, Hara A, Mori H, Shibata T. Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells. Br J Cancer 2008;99:647-54. [PMID: 18665171 DOI: 10.1038/sj.bjc.6604521] [Cited by in Crossref: 130] [Cited by in F6Publishing: 92] [Article Influence: 10.0] [Reference Citation Analysis]
15 Li Y, Gao X, Lou Y. Interactions of tea polyphenols with intestinal microbiota and their implication for cellular signal conditioning mechanism. J Food Biochem 2019;43:e12953. [PMID: 31368563 DOI: 10.1111/jfbc.12953] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
16 Yin SY, Jian FY, Chen YH, Chien SC, Hsieh MC, Hsiao PW, Lee WH, Kuo YH, Yang NS. Induction of IL-25 secretion from tumour-associated fibroblasts suppresses mammary tumour metastasis. Nat Commun 2016;7:11311. [PMID: 27089063 DOI: 10.1038/ncomms11311] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
17 Flis S, Gnyszka A, Misiewicz-Krzemińska I, Spławiński J. Decytabine enhances cytotoxicity induced by oxaliplatin and 5-fluorouracil in the colorectal cancer cell line Colo-205. Cancer Cell Int 2009;9:10. [PMID: 19397792 DOI: 10.1186/1475-2867-9-10] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
18 García-domínguez P, Lepore I, Erb C, Gronemeyer H, Altucci L, Álvarez R, de Lera ÁR. Total synthesis of the proposed structures of the DNA methyl transferase inhibitors peyssonenynes, and structural revision of peyssonenyne B. Org Biomol Chem 2011;9:6979. [DOI: 10.1039/c1ob05932g] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
19 Schleithoff C, Voelter-Mahlknecht S, Dahmke IN, Mahlknecht U. On the epigenetics of vascular regulation and disease. Clin Epigenetics 2012;4:7. [PMID: 22621747 DOI: 10.1186/1868-7083-4-7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
20 Skowronski K, Dubey S, Rodenhiser D, Coomber B. Ischemia dysregulates DNA methyltransferases and p16INK4a methylation in human colorectal cancer cells. Epigenetics 2010;5:547-56. [PMID: 20543577 DOI: 10.4161/epi.5.6.12400] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 3.9] [Reference Citation Analysis]
21 Kawakami K, Yamamura S, Hirata H, Ueno K, Saini S, Majid S, Tanaka Y, Kawamoto K, Enokida H, Nakagawa M, Dahiya R. Secreted frizzled-related protein-5 is epigenetically downregulated and functions as a tumor suppressor in kidney cancer. Int J Cancer 2011;128:541-50. [PMID: 20340127 DOI: 10.1002/ijc.25357] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
22 Gemenetzi M, Lotery AJ. The role of epigenetics in age-related macular degeneration. Eye (Lond) 2014;28:1407-17. [PMID: 25233816 DOI: 10.1038/eye.2014.225] [Cited by in Crossref: 43] [Cited by in F6Publishing: 30] [Article Influence: 6.1] [Reference Citation Analysis]
23 Van Beneden K, Mannaerts I, Pauwels M, Van den Branden C, van Grunsven LA. HDAC inhibitors in experimental liver and kidney fibrosis. Fibrogenesis Tissue Repair 2013;6:1. [PMID: 23281659 DOI: 10.1186/1755-1536-6-1] [Cited by in Crossref: 56] [Cited by in F6Publishing: 46] [Article Influence: 7.0] [Reference Citation Analysis]
24 Zhou XQ, Huang SY, Zhang DS, Zhang SZ, Li WG, Chen ZW, Wu HW. Effects of 5-aza-2'deoxycytidine on RECK gene expression and tumor invasion in salivary adenoid cystic carcinoma. Braz J Med Biol Res. 2015;48:254-260. [PMID: 25517920 DOI: 10.1590/1414-431X20144102] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
25 Gao S, Mobley A, Miller C, Boklan J, Chandra J. Potentiation of reactive oxygen species is a marker for synergistic cytotoxicity of MS-275 and 5-azacytidine in leukemic cells. Leuk Res 2008;32:771-80. [PMID: 18031811 DOI: 10.1016/j.leukres.2007.09.007] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 3.0] [Reference Citation Analysis]
26 Pereira R, Benedetti R, Pérez-rodríguez S, Nebbioso A, García-rodríguez J, Carafa V, Stuhldreier M, Conte M, Rodríguez-barrios F, Stunnenberg HG, Gronemeyer H, Altucci L, de Lera ÁR. Indole-Derived Psammaplin A Analogues as Epigenetic Modulators with Multiple Inhibitory Activities. J Med Chem 2012;55:9467-91. [DOI: 10.1021/jm300618u] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 4.2] [Reference Citation Analysis]
27 Hassanzadeh M, Mahernia S, Caprini G, Fossati G, Adib M, Moakedi F, Amanlou M. Epigenetic-based cancer therapeutics: new potential HDAC8 inhibitors. Journal of Biomolecular Structure and Dynamics. [DOI: 10.1080/07391102.2020.1813203] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
28 Pérez-Cárdenas E, Taja-Chayeb L, Trejo-Becerril C, Chanona-Vilchis J, Chávez-Blanco A, Domínguez-Gómez G, Langley E, García-Carrancá A, Dueñas-González A. Antimetastatic effect of epigenetic drugs, hydralazine and valproic acid, in Ras-transformed NIH 3T3 cells. Onco Targets Ther 2018;11:8823-33. [PMID: 30584338 DOI: 10.2147/OTT.S187306] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Chi HC, Tsai CY, Tsai MM, Lin KH. Impact of DNA and RNA Methylation on Radiobiology and Cancer Progression. Int J Mol Sci 2018;19:E555. [PMID: 29439529 DOI: 10.3390/ijms19020555] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
30 Komorowsky C, Samarin J, Rehm M, Guidolin D, Goppelt-Struebe M. Hic-5 as a regulator of endothelial cell morphology and connective tissue growth factor gene expression. J Mol Med (Berl) 2010;88:623-31. [PMID: 20333347 DOI: 10.1007/s00109-010-0608-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
31 Li H, Zhang Z, Gao C, Wu S, Duan Q, Wu H, Wang C, Shen Q, Yin T. Combination chemotherapy of valproic acid (VPA) and gemcitabine regulates STAT3/Bmi1 pathway to differentially potentiate the motility of pancreatic cancer cells. Cell Biosci 2019;9:50. [PMID: 31244991 DOI: 10.1186/s13578-019-0312-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 4.5] [Reference Citation Analysis]
32 Leri M, Scuto M, Ontario ML, Calabrese V, Calabrese EJ, Bucciantini M, Stefani M. Healthy Effects of Plant Polyphenols: Molecular Mechanisms. Int J Mol Sci 2020;21:E1250. [PMID: 32070025 DOI: 10.3390/ijms21041250] [Cited by in Crossref: 108] [Cited by in F6Publishing: 80] [Article Influence: 108.0] [Reference Citation Analysis]
33 Coronel J, Cetina L, Pacheco I, Trejo-Becerril C, González-Fierro A, de la Cruz-Hernandez E, Perez-Cardenas E, Taja-Chayeb L, Arias-Bofill D, Candelaria M, Vidal S, Dueñas-González A. A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer. Preliminary results. Med Oncol 2011;28 Suppl 1:S540-6. [PMID: 20931299 DOI: 10.1007/s12032-010-9700-3] [Cited by in Crossref: 77] [Cited by in F6Publishing: 72] [Article Influence: 7.0] [Reference Citation Analysis]
34 Flis S, Gnyszka A, Flis K. DNA methyltransferase inhibitors improve the effect of chemotherapeutic agents in SW48 and HT-29 colorectal cancer cells. PLoS One 2014;9:e92305. [PMID: 24676085 DOI: 10.1371/journal.pone.0092305] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 4.1] [Reference Citation Analysis]
35 Maldonado L, Hoque MO. Epigenomics and ovarian carcinoma. Biomark Med 2010;4:543-70. [PMID: 20701443 DOI: 10.2217/bmm.10.72] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
36 Murakami M, Kaul R, Robertson ES. MTA1 expression is linked to ovarian cancer. Cancer Biol Ther 2008;7:1468-70. [PMID: 18836297 DOI: 10.4161/cbt.7.9.6885] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
37 Barrio-Real L, Benedetti LG, Engel N, Tu Y, Cho S, Sukumar S, Kazanietz MG. Subtype-specific overexpression of the Rac-GEF P-REX1 in breast cancer is associated with promoter hypomethylation. Breast Cancer Res 2014;16:441. [PMID: 25248717 DOI: 10.1186/s13058-014-0441-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
38 Lo PK, Sukumar S. Epigenomics and breast cancer. Pharmacogenomics 2008;9:1879-902. [PMID: 19072646 DOI: 10.2217/14622416.9.12.1879] [Cited by in Crossref: 114] [Cited by in F6Publishing: 98] [Article Influence: 9.5] [Reference Citation Analysis]
39 Beltran AS, Sun X, Lizardi PM, Blancafort P. Reprogramming epigenetic silencing: artificial transcription factors synergize with chromatin remodeling drugs to reactivate the tumor suppressor mammary serine protease inhibitor. Mol Cancer Ther 2008;7:1080-90. [PMID: 18483297 DOI: 10.1158/1535-7163.MCT-07-0526] [Cited by in Crossref: 53] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
40 Kobow K, Jeske I, Hildebrandt M, Hauke J, Hahnen E, Buslei R, Buchfelder M, Weigel D, Stefan H, Kasper B, Pauli E, Blümcke I. Increased reelin promoter methylation is associated with granule cell dispersion in human temporal lobe epilepsy. J Neuropathol Exp Neurol 2009;68:356-64. [PMID: 19287316 DOI: 10.1097/NEN.0b013e31819ba737] [Cited by in Crossref: 113] [Cited by in F6Publishing: 56] [Article Influence: 9.4] [Reference Citation Analysis]
41 Arora I, Sharma M, Tollefsbol TO. Combinatorial Epigenetics Impact of Polyphenols and Phytochemicals in Cancer Prevention and Therapy. Int J Mol Sci 2019;20:E4567. [PMID: 31540128 DOI: 10.3390/ijms20184567] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 17.0] [Reference Citation Analysis]
42 Gemenetzi M, Lotery AJ. Epigenetics in age-related macular degeneration: new discoveries and future perspectives. Cell Mol Life Sci 2020;77:807-18. [PMID: 31897542 DOI: 10.1007/s00018-019-03421-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
43 Kanda M, Sugimoto H, Kodera Y. Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma. World J Gastroenterol. 2015;21:10584-10597. [PMID: 26457018 DOI: 10.3748/wjg.v21.i37.10584] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 41] [Article Influence: 7.4] [Reference Citation Analysis]
44 Alghamdi S, Khan I, Beeravolu N, McKee C, Thibodeau B, Wilson G, Chaudhry GR. BET protein inhibitor JQ1 inhibits growth and modulates WNT signaling in mesenchymal stem cells. Stem Cell Res Ther 2016;7:22. [PMID: 26830473 DOI: 10.1186/s13287-016-0278-3] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
45 Boland CR, Shin SK, Goel A. Promoter methylation in the genesis of gastrointestinal cancer. Yonsei Med J. 2009;50:309-321. [PMID: 19568590 DOI: 10.3349/ymj.2009.50.3.309] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
46 García P, Martín-Pastor M, de Lera AR, Alvarez R. Determination of the geometry of acetoxyendiynes and acetoxyenynes by NMR heteronuclear (13)C-(1)H scalar couplings and (13)C NMR chemical shifts. Structural assignment of the oxylipin natural products peyssonenynes A and B. Magn Reson Chem 2010;48:543-9. [PMID: 20535768 DOI: 10.1002/mrc.2618] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
47 Liu Z, Sun J, Wang X, Cao Z. MicroRNA-129-5p promotes proliferation and metastasis of hepatocellular carcinoma by regulating the BMP2 gene. Exp Ther Med 2021;21:257. [PMID: 33603864 DOI: 10.3892/etm.2021.9688] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Hoffmann HH, Palese P, Shaw ML. Modulation of influenza virus replication by alteration of sodium ion transport and protein kinase C activity. Antiviral Res 2008;80:124-34. [PMID: 18585796 DOI: 10.1016/j.antiviral.2008.05.008] [Cited by in Crossref: 63] [Cited by in F6Publishing: 61] [Article Influence: 4.8] [Reference Citation Analysis]
49 Mahalingaiah PK, Ponnusamy L, Singh KP. Oxidative stress-induced epigenetic changes associated with malignant transformation of human kidney epithelial cells. Oncotarget 2017;8:11127-43. [PMID: 27655674 DOI: 10.18632/oncotarget.12091] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 8.3] [Reference Citation Analysis]
50 Ribatti D, Tamma R. Epigenetic control of tumor angiogenesis. Microcirculation 2020;27:e12602. [PMID: 31863494 DOI: 10.1111/micc.12602] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]